Advertisement
News
Advertisement

InVivo names Mark Perrin its new CEO

Thu, 01/02/2014 - 9:47am
Mass Device

InVivo Therapeutics' new CEO Mark Perrin comes from a background in biotech consulting and leadership.

InVivo appoints new CEO

InVivo Therapeutics (OTC:NVIV) named Mark Perrin as its new CEO, handing him the keys to the corner office effective January 6.

Interim chief Michael Astrue will assist Perrin with the transition, the company said. Astrue took on the position after the resignation of co-founder Frank Reynolds in August, who stepped down over health issues.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading